Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXD3KU
|
||||
| Drug Name |
(S)-2-amino-4-(3-(cyclopropylethynyl)phenyl)-4-(4-(difluoromethoxy)-3-methylphenyl)-1-methyl-1H-imidazol-5(4H)-one
|
||||
| Synonyms |
CHEMBL1270630
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C23H21F2N3O2
|
||||
| Canonical SMILES |
CN1C(=N[C@](C1=O)(c2ccc(OC(F)F)c(C)c2)c3cccc(c3)C#CC4CC4)N
|
||||
| InChI |
InChI=1S/C23H21F2N3O2/c1-14-12-18(10-11-19(14)30-21(24)25)23(20(29)28(2)22(26)27-23)17-5-3-4-16(13-17)9-8-15-6-7-15/h3-5,10-13,15,21H,6-7H2,1-2H3,(H2,26,27)/t23-/m0/s1
|
||||
| InChIKey |
PWZLUGHNDYWEDU-QHCPKHFHSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Renin, renal | Target Info | [1587926] | ||
| Cathepsin D | Target Info | [1587926] | |||
| BioCyc Pathway | Thyroid hormone biosynthesis | ||||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| Pathway Interaction Database | LKB1 signaling events | ||||
| Ceramide signaling pathway | |||||
| Direct p53 effectors | |||||
| Validated nuclear estrogen receptor alpha network | |||||
| PathWhiz Pathway | Angiotensin Metabolism | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.